======= PELI1 =======


== Gene Information ==
  * **<color #00a2e8>Official Symbol</color>**: PELI1
  * **<color #00a2e8>Official Name</color>**: pellino E3 ubiquitin protein ligase 1
  * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A
  * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57162|57162]]
  * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q96FA3|Q96FA3]]
  * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=PELI1&organism=9606|BioGRID]]
  * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PELI1|Open PubMed]]
  * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/614797|Open OMIM]]

== Function Summary ==
  * **<color #00a2e8>Entrez Summary</color>**: N/A
  * **<color #00a2e8>UniProt Summary</color>**:  E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates 'Lys-63'-linked polyubiquitination of IRAK1 allowing subsequent NF-kappa-B activation. {ECO:0000269|PubMed:12496252, ECO:0000269|PubMed:17675297}.

<button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button>
<button type='primary' size='sm' modal='GO_terms'>GO Terms</button>


<modal id='Pfam_Domains' size='lg' title='Pfam Domains'>
|Pellino|
</modal>

<modal id='GO_terms' size='lg' title='GO Terms'>
|regulation of Toll signaling pathway|
|Toll signaling pathway|
|positive regulation of toll-like receptor 3 signaling pathway|
|positive regulation of toll-like receptor 4 signaling pathway|
|regulation of toll-like receptor 3 signaling pathway|
|negative regulation of necroptotic process|
|negative regulation of programmed necrotic cell death|
|ubiquitin-ubiquitin ligase activity|
|negative regulation of necrotic cell death|
|regulation of necroptotic process|
|regulation of programmed necrotic cell death|
|regulation of toll-like receptor 4 signaling pathway|
|positive regulation of toll-like receptor signaling pathway|
|regulation of necrotic cell death|
|protein K63-linked ubiquitination|
|positive regulation of B cell proliferation|
|response to dsRNA|
|protein K48-linked ubiquitination|
|negative regulation of T cell proliferation|
|regulation of B cell proliferation|
|regulation of toll-like receptor signaling pathway|
|negative regulation of lymphocyte proliferation|
|negative regulation of mononuclear cell proliferation|
|negative regulation of leukocyte proliferation|
|negative regulation of NF-kappaB transcription factor activity|
|interleukin-1-mediated signaling pathway|
|negative regulation of T cell activation|
|positive regulation of protein ubiquitination|
|negative regulation of leukocyte cell-cell adhesion|
|positive regulation of lymphocyte proliferation|
|positive regulation of mononuclear cell proliferation|
|positive regulation of protein modification by small protein conjugation or removal|
|positive regulation of leukocyte proliferation|
|negative regulation of lymphocyte activation|
|regulation of T cell proliferation|
|negative regulation of DNA-binding transcription factor activity|
|positive regulation of B cell activation|
|negative regulation of cell-cell adhesion|
|cellular response to interleukin-1|
|negative regulation of leukocyte activation|
|positive regulation of I-kappaB kinase/NF-kappaB signaling|
|negative regulation of cell activation|
|response to interleukin-1|
|regulation of protein ubiquitination|
|regulation of B cell activation|
|regulation of lymphocyte proliferation|
|regulation of mononuclear cell proliferation|
|ubiquitin protein ligase activity|
|regulation of leukocyte proliferation|
|regulation of protein modification by small protein conjugation or removal|
|regulation of I-kappaB kinase/NF-kappaB signaling|
|negative regulation of cell adhesion|
|regulation of leukocyte cell-cell adhesion|
|protein polyubiquitination|
|response to lipopolysaccharide|
|regulation of T cell activation|
|proteasome-mediated ubiquitin-dependent protein catabolic process|
|response to molecule of bacterial origin|
|positive regulation of innate immune response|
|proteasomal protein catabolic process|
|positive regulation of lymphocyte activation|
|positive regulation of response to biotic stimulus|
|regulation of cell-cell adhesion|
|positive regulation of leukocyte activation|
|positive regulation of cell activation|
|regulation of DNA-binding transcription factor activity|
|negative regulation of immune system process|
|positive regulation of cytokine production|
|regulation of innate immune response|
|positive regulation of defense response|
|positive regulation of multi-organism process|
|regulation of lymphocyte activation|
|regulation of response to biotic stimulus|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|regulation of leukocyte activation|
|positive regulation of response to external stimulus|
|cellular protein catabolic process|
|regulation of cell activation|
|cytokine-mediated signaling pathway|
|negative regulation of cell population proliferation|
|regulation of cell adhesion|
|protein catabolic process|
|protein ubiquitination|
|response to bacterium|
|regulation of cytokine production|
|regulation of defense response|
|protein modification by small protein conjugation|
|regulation of multi-organism process|
|response to lipid|
|positive regulation of immune response|
|negative regulation of programmed cell death|
|cellular macromolecule catabolic process|
|positive regulation of cell population proliferation|
|response to organic cyclic compound|
|protein modification by small protein conjugation or removal|
|negative regulation of cell death|
|cellular response to cytokine stimulus|
|positive regulation of intracellular signal transduction|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|response to nitrogen compound|
|regulation of response to external stimulus|
|response to cytokine|
|negative regulation of molecular function|
|positive regulation of immune system process|
|regulation of immune response|
|positive regulation of protein modification process|
|proteolysis|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|regulation of response to stress|
|response to oxygen-containing compound|
|regulation of programmed cell death|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|regulation of immune system process|
|positive regulation of signal transduction|
|regulation of cell death|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
|organic substance catabolic process|
|cellular catabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
</modal>
\\

 === CRISPR Data ===
<button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button>
<button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button>
<button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button>

<modal id='Compound_Hit' size='lg' title='Compound Hit'>
^Screen^Score^
|[[:results:exp538|ZLN024 50μM R08 exp538]]|1.74|
|[[:results:exp453|B02 10μM R08 exp453]]|1.83|
</modal>

<modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'>
No correlation found to any other genes in chemogenomics.
</modal>

<modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'>
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
</modal>

== Essentiality in NALM6  ==
    * **<color #00a2e8>Essentiality Rank</color>**: 13303
    * **<color #00a2e8>Expression level (log2 read counts)</color>**: 4.2 
<button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button>
<modal id='Dist_expr' size='lg' title='PELI1 Expression in NALM6 Cells: 4.2'>
{{:chemogenomics:nalm6 dist.png?nolink |}}
</modal>